Rx/reimbursement adult incontinence recorded slightly higher value and volume growth in 2020 compared to 2019. This was most likely caused by stockpiling due to the COVID-19 pandemic, reflecting the generally vulnerable nature of consumers due to their age or underlying health conditions.
In the Czech Republic, incontinence is often referred to as a problem affecting only women. However, the reality is that many older men also suffer from the condition and are eligible to obtain products on a reimbursement basis.
Rx/reimbursement adult incontinence is expected to record stronger average value growth at constant 2020 prices over the forecast period compared to the review period as the category continues to benefit from a rise in the number of consumers suffering incontinence. This is set to occur amid ongoing growth in the size of the population aged 65+ and growing consumer awareness of incontinence as a condition.
The Czech government plans to increase the level of reimbursement for consumers of moderate and heavy incontinence products prescribed by their doctor, which may potentially have a strong positive impact on sales of rx/reimbursement adult incontinence. However, the precise amount and date of such an increase has yet to be determined.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Czech Republic with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Czech Republic, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page